- Home
- PSNL vs SGRY Comparison
PSNL vs SGRY Comparison
Compare PSNL & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSNL | SGRY |
|---|---|---|
| Founded | 2011 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | PSNL | SGRY |
|---|---|---|
| Price | $16.60 | $13.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $12.20 | ★ $22.25 |
| AVG Volume (30 Days) | ★ 3.6M | 2.6M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.58 | ★ 54.14 |
| EPS | N/A | ★ N/A |
| Revenue | $69,648,000.00 | ★ $1,145,438,000.00 |
| Revenue This Year | $15.34 | $5.09 |
| Revenue Next Year | $41.46 | $5.67 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.96 | $11.41 |
| 52 Week High | $18.89 | $23.44 |
Technical Indicators
Market Signals| Indicator | PSNL | SGRY |
|---|---|---|
| Relative Strength Index (RSI) | 57.30 | 45.85 |
| Support Level | $7.41 | $13.31 |
| Resistance Level | $18.89 | $15.08 |
| Average True Range (ATR) | 0.88 | 0.66 |
| MACD | -0.08 | 0.05 |
| Stochastic Oscillator | 48.43 | 50.40 |
Price Performance
Historical ComparisonAbout PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.